Loading clinical trials...
Loading clinical trials...
An Open Label, Proof of Mechanism Study to Explore the Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Conditions
Interventions
BBT-401-1S
Locations
2
New Zealand
P3 Research
Tauranga, New Zealand
P3 Research
Wellington, New Zealand
Start Date
June 1, 2021
Primary Completion Date
August 4, 2021
Completion Date
August 24, 2021
Last Updated
October 1, 2021
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Bridge Biotherapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions